Dynatronics is a leading medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. The Company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The Company's products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin®, Solaris™, Hausmann™, Physician's Choice®, and PROTEAM™, among others.

Company profile
Ticker
DYNT
Exchange
Website
CEO
John A. Krier
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
3M • Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Resmed • Hill-Rom • Nuvasive • Integra Lifesciences ...
Former names
DYNATRONICS LASER CORP
SEC CIK
Corporate docs
Subsidiaries
Dynatronics Distribution Co. LLC • Hausmann Enterprises, LLC • Dynatronics Medical Products, LLC • Bird & Cronin, LLC ...
IRS number
870398434
DYNT stock data
Analyst ratings and price targets
Investment data
Securities sold
Number of investors
Calendar
12 May 22
12 Aug 22
30 Jun 23
Financial summary
Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 21 | Jun 20 | Jun 19 | Jun 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.47M | 2.47M | 2.47M | 2.47M | 2.47M | 2.47M |
Cash burn (monthly) | 366.86K | 181.51K | 478.51K | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 1.61M | 798.57K | 2.11M | n/a | n/a | n/a |
Cash remaining | 858.8K | 1.67M | 367.58K | n/a | n/a | n/a |
Runway (months of cash) | 2.3 | 9.2 | 0.8 | n/a | n/a | n/a |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Jul 22 | Norman Roegner III | Common Stock | Grant | Acquire A | No | No | 0.64 | 15,180 | 9.72K | 24,472 |
8 Jul 22 | John Anthony Krier | Common Stock | Grant | Acquire A | No | No | 0.63 | 12,500 | 7.88K | 47,322 |
7 Jul 22 | Baker Brian D. | Common Stock | Other | Acquire J | No | No | 0 | 8,550 | 0 | 127,623 |
7 Jul 22 | Essig Stuart | Common Stock | Grant | Acquire A | Yes | No | 0 | 5,000 | 0 | 110,601 |
7 Jul 22 | Essig Stuart | Common Stock | Other | Acquire J | Yes | No | 0 | 20,376 | 0 | 258,474 |
7 Jul 22 | Essig Stuart | Common Stock | Other | Acquire J | No | No | 0 | 101,520 | 0 | 1,853,503 |
7 Jul 22 | Enright Erin S. | Common Stock | Grant | Acquire A | No | No | 0 | 5,000 | 0 | 110,601 |
7 Jul 22 | Enright Erin S. | Common Stock | Other | Acquire J | Yes | No | 0 | 20,378 | 0 | 258,474 |
7 Jul 22 | Enright Erin S. | Common Stock | Other | Acquire J | Yes | No | 0 | 101,520 | 0 | 1,853,503 |
Institutional ownership, Q1 2022
8.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 14 |
Opened positions | 1 |
Closed positions | 7 |
Increased positions | 2 |
Reduced positions | 5 |
13F shares | Current |
---|---|
Total value | 1.07M |
Total shares | 1.48M |
Total puts | 0 |
Total calls | 0 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Renaissance Technologies | 1.03M | $748K |
Vanguard | 106.19K | $77K |
Albion Financial | 90K | $65K |
Advisor | 82.08K | $60K |
Geode Capital Management | 61.16K | $44K |
BAC Bank Of America | 20K | $15K |
BLK Blackrock | 18.48K | $13K |
HRT Financial | 16.98K | $12K |
Squarepoint Ops | 15.7K | $11K |
Two Sigma Advisers | 11.1K | $8K |
Financial report summary
?Management Discussion
- Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
- We design, manufacture, and sell a broad range of restorative products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Through our distribution channels, we market and sell to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals.
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
Removed:
facility, February, line
Financial reports
Current reports
8-K
Dynatronics Announces Appointment of New Chief Information Officer; Krier to add Chief Financial Officer responsibilities
6 Jul 22
8-K
Results of Operations and Financial Condition
12 May 22
8-K
Dynatronics Corporation Schedules Conference Call and Webcast to Provide Business Update and Discuss Third Quarter of Fiscal Year 2022 Results
28 Apr 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
25 Feb 22
8-K
Dynatronics Corporation Reports Second Quarter Financial Results and Business Highlights
10 Feb 22
8-K
Dynatronics Corporation Schedules Conference Call and Webcast to Provide Business Update and Discuss Second Quarter of Fiscal Year 2022 Results
27 Jan 22
8-K
Dynatronics Corporation Announces Brian Baker as Chief Operating Officer
19 Jan 22
8-K
Submission of Matters to a Vote of Security Holders
23 Nov 21
8-K
Dynatronics Corporation Reports First Quarter Financial Results and Business Highlights
12 Nov 21
8-K
Dynatronics Corporation Schedules Conference Call and Webcast to Provide Business Update and Discuss First Quarter of Fiscal Year 2022 Results
28 Oct 21
Registration and prospectus
424B5
Prospectus supplement for primary offering
17 Sep 21
S-8
Registration of securities for employees
17 Aug 21
424B5
Prospectus supplement for primary offering
12 Mar 20
S-8
Registration of securities for employees
26 Sep 19
S-3/A
Shelf registration (amended)
23 Oct 17
S-3
Shelf registration
12 Oct 17
Other
EFFECT
Notice of effectiveness
2 Jul 21
CORRESP
Correspondence with SEC
29 Jun 21
UPLOAD
Letter from SEC
24 May 21
EFFECT
Notice of effectiveness
24 May 18
CORRESP
Correspondence with SEC
21 May 18
EFFECT
Notice of effectiveness
25 Oct 17
CORRESP
Correspondence with SEC
23 Oct 17
CORRESP
Correspondence with SEC
23 Apr 17
EFFECT
Notice of effectiveness
23 Apr 17
UPLOAD
Letter from SEC
18 Apr 17
Ownership
4
DYNATRONICS / Norman Roegner III ownership change
22 Jul 22
4
Change in insider ownership
12 Jul 22
4
DYNATRONICS / R Scott Ward ownership change
12 Jul 22
4
DYNATRONICS / BRIAN LARKIN ownership change
12 Jul 22
4
DYNATRONICS / SCOTT KLOSTERMAN ownership change
12 Jul 22
4
DYNATRONICS / DAVID B HOLTZ ownership change
12 Jul 22
4
DYNATRONICS / STUART ESSIG ownership change
12 Jul 22
4
DYNATRONICS / ERIN S. ENRIGHT ownership change
12 Jul 22
4
DYNATRONICS / Brian D. Baker ownership change
12 Jul 22
4
DYNATRONICS / John Anthony Krier ownership change
12 Jul 22
Transcripts
2022 Q3
Earnings call transcript
12 May 22
2022 Q2
Earnings call transcript
10 Feb 22
2022 Q1
Earnings call transcript
11 Nov 21
2021 Q4
Earnings call transcript
23 Sep 21
2021 Q3
Earnings call transcript
13 May 21
2021 Q2
Earnings call transcript
11 Feb 21
2021 Q1
Earnings call transcript
12 Nov 20
2020 Q4
Earnings call transcript
24 Sep 20
2020 Q3
Earnings call transcript
14 May 20
2020 Q2
Earnings call transcript
11 Feb 20
Reddit threads
Picks for 2022-06-08
8 Jun 22
Daily Discussion Thread - May 12th, 2022
12 May 22
Daily Discussion Thread - May 11th, 2022
11 May 22
Daily Discussion Thread - February 10th, 2022
10 Feb 22
Daily Discussion Thread - February 9th, 2022
9 Feb 22
Daily Discussion Thread - February 8th, 2022
8 Feb 22
Daily Discussion Thread - February 7th, 2022
7 Feb 22
Are there any companies whose fundamentals have improved since November but are now down 20% or more off their 52 week high?
17 Jan 22
DYNT???
9 Jan 22
eBay, due for some love?
9 Jan 22